VRN101099, Brain Permeable HER2 Kinase Inhibitor, Shows the Anti-tumor Activity in Preclinical Models of HER2-positive Cancers

被引：0
|
作者：
Ko, Yikyung
Yoo, Jihye
Jung, Hong-Ryul
Lim, Hyerim
Lee, YeongDeok
Kim, Se Hyuk
Shin, Dong Guk
Cho, Serin
Heo, Myung Hoe
Kim, Haelee
Cho, Ha Yeon
Han, Ah Reum
Ko, Eunhwa
Choi, Hwan Geun
Kim, Deakwon
Kim, Sunghwan
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P1-11-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-11-03
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Antitumor Activity of TAK-285, an Investigational, Non-Pgp Substrate HER2/EGFR Kinase Inhibitor, in Cultured Tumor Cells, Mouse and Rat Xenograft Tumors, and in an HER2-Positive Brain Metastasis Model
    Nakayama, Akiko
    Takagi, Shinji
    Yusa, Tadashi
    Yaguchi, Masahiro
    Hayashi, Akira
    Tamura, Toshiya
    Kawakita, Youichi
    Ishikawa, Tomoyasu
    Ohta, Yoshikazu
    JOURNAL OF CANCER, 2013, 4 (07): : 557 - 565
  • [42] Efficacy of HER2 ADCs against HER2 inhibitor resistance alterations in the PI3K and MAPK pathways in HER2-positive breast cancer
    Ferraro, Emanuela
    Safonov, Anton
    Chen, Yuan
    White, Charlie
    Marra, Antonio
    Ahmed, Mehnaj
    Acevedo, Barbara
    Dang, Chau T.
    Modi, Shanu
    Solit, David B.
    Norton, Larry
    Robson, Mark E.
    Reis-Filho, Jorge
    Chandarlapaty, Sarat
    Razavi, Pedram
    CANCER RESEARCH, 2023, 83 (05)
  • [43] Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers
    Baldassarre, Tomas
    Truesdell, Peter
    Craig, Andrew W.
    BREAST CANCER RESEARCH, 2017, 19
  • [44] Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers
    Tomas Baldassarre
    Peter Truesdell
    Andrew W. Craig
    Breast Cancer Research, 19
  • [45] HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib
    Valabrega, Giorgio
    Capellero, Sonia
    Cavalloni, Giuliana
    Zaccarello, Gianluca
    Petrelli, Annalisa
    Migliardi, Giorgia
    Milani, Andrea
    Peraldo-Neia, Caterina
    Gammaitoni, Loretta
    Sapino, Anna
    Pecchioni, Carla
    Moggio, Aldo
    Giordano, Silvia
    Aglietta, Massimo
    Montemurro, Filippo
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 130 (01) : 29 - 40
  • [46] HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib
    Giorgio Valabrega
    Sonia Capellero
    Giuliana Cavalloni
    Gianluca Zaccarello
    Annalisa Petrelli
    Giorgia Migliardi
    Andrea Milani
    Caterina Peraldo-Neia
    Loretta Gammaitoni
    Anna Sapino
    Carla Pecchioni
    Aldo Moggio
    Silvia Giordano
    Massimo Aglietta
    Filippo Montemurro
    Breast Cancer Research and Treatment, 2011, 130 : 29 - 40
  • [47] Clinical significance of metastatic-tumor HER2 status in patients with HER2-positive primary breast cancer
    Niikura, N.
    Liu, J.
    Hayashi, N.
    Mittendorf, E. A.
    Gong, Y.
    Palla, S. L.
    Tokuda, Y.
    Gonzalez-Angulo, A. M.
    Hortobagyi, G. N.
    Ueno, N. T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [48] miR-489 function as tumor suppressor miRNA by targeting HER2 in HER2-positive breast cancer
    Patel, Yogin
    Shah, Nirav
    Botbyl, Racheal
    Lee, Jishin
    Chen, Hexin
    CANCER RESEARCH, 2015, 75
  • [49] HER2 intratumoral heterogeneity is independently associated with incomplete response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma
    Hou, Yanjun
    Nitta, Hiroaki
    Wei, Lai
    Banks, Peter M.
    Portier, Bryce
    Parwani, Anil V.
    Li, Zaibo
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (02) : 447 - 457
  • [50] Clinicopathologic Characteristics of HER2-positive Metastatic Colorectal Cancer and Detection of HER2 in Plasma Circulating Tumor DNA
    Wei, Qing
    Zhang, Yinjie
    Gao, Jing
    Li, Jian
    Li, Jie
    Li, Yanyan
    Zhou, Jun
    Lu, Ming
    Gong, Jifang
    Zhang, Xiaotian
    Shen, Lin
    Sun, Yu
    Chang, Lianpeng
    Wang, Xicheng
    CLINICAL COLORECTAL CANCER, 2019, 18 (03) : 175 - 182
12345